Exchange: NASDAQ·Updated 10:03 AM EDT
VCYT logo

VCYT Veracyte Inc

$41.09
$1.30
(3.25%)
Today
EarningsNov 3
Mkt Cap$3.2B
Vol46,589.00

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
47

Neutral Sentiment

How do you feel about VCYT?

Advertisement|Remove ads.